Search results
Results from the Health.Zone Content Network
Primary sclerosing cholangitis ( PSC) is a long-term progressive disease of the liver and gallbladder characterized by inflammation and scarring of the bile ducts, which normally allow bile to drain from the gallbladder. Affected individuals may have no symptoms or may experience signs and symptoms of liver disease, such as yellow discoloration ...
PSC develops slowly. You may have it for years before you notice any symptoms. Some of the signs are: Fatigue. Itchy skin. Yellowish skin and eyes caused by a condition called jaundice. As PSC ...
Anti-mitochondrial antibody. Anti-mitochondrial antibodies ( AMA) are autoantibodies, consisting of immunoglobulins formed against mitochondria, [1] primarily the mitochondria in cells of the liver . The presence of AMA in the blood or serum of a person may be indicative of the presence of, or the potential to develop, the autoimmune disease ...
PSC is highly associated with inflammatory bowel disease (IBD). About 60–80% of people with PSC have irritable bowel disorder (IBD), according to 2023 research , and in about 80% of cases, they ...
Frequency. 1 in 3,000–4,000 people. Primary biliary cholangitis ( PBC ), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. [1] [2] [3] It results from a slow, progressive destruction of the small bile ducts of the liver, causing bile and other toxins to build up in the liver, a condition called cholestasis.
yellowing of the skin, or jaundice. pain in the upper right abdomen. swelling, or edema of the hands and feet. a buildup of fluid in the abdomen. dry mouth and eyes. weight loss. An AMA test is ...
An antinuclear antibody test is a blood test that looks for certain kinds of antibodies in your body. It’s also called an ANA or FANA (fluorescent antinuclear antibody) test. Antibodies are ...
Anti-sp100 antibodies. Schematic representation of antibody. Anti-sp100 antibodies are found in association with primary biliary cirrhosis. [1] The autoimmune target of anti-sp100 is the sp100 nuclear antigen which was identified by its association with primary biliary cirrhosis. 20-30% of patients with primary biliary cirrhosis have sp100 Abs.